A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred.
Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity and genetic defects of lysosomal acid lipase (LAL). The strikingly more severe course of WD is caused by genetic defects of LAL that leave no residual enzymatic activity. Mutations at the exon 8/intron 8 transition of the LAL gene have been identified in several CESD and WD patients and are responsible for the manifestation of the disease. We have determined the genetic defect in a 3-month-old boy of African origin affected by WD. No enzymatic activity of the lysosomal acid lipase was detectable in white blood cells and cultured fibroblasts. Analysis of his LAL cDNA and genomic DNA revealed that he was homozygous for a mutation at position -3 of the exon 8 splice donor site. A C-->T transition leads to a nonsense codon and to a premature termination of the LAL protein at amino acid 277. Due to this mutation, a shorter LAL mRNA species was also generated that lacked exon 8 and was deficient of the nonsense codon. As a consequence, the protein synthesis proceeded to the natural termination codon, but the enzyme generated had an internal deletion of 24 amino acids (254-277) and was also inactive. These findings, together with our previous observations when analyzing the mutations in WD and CESD patients lead to the conclusion that the more severe WD is due to mutations that absolutely abolish lysosomal acid lipase (LAL) enzyme activity and the cholesteryl ester storage disease phenotype is due to mutations that allow some residual LAL activity to be manifested.
Ries
S
S
Institute of Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany.
Aslanidis
C
C
Fehringer
P
P
Carel
J C
JC
Gendrel
D
D
Schmitz
G
G
D017398:Alternative Splicing; D001483:Base Sequence; D002478:Cells, Cultured; D017931:DNA Primers / Q000737:chemistry; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D007223:Infant; D008049:Lipase / Q000235:genetics* / Q000378:metabolism; D016464:Lysosomal Storage Diseases / Q000201:enzymology / Q000235:genetics*; D008247:Lysosomes / Q000201:enzymology* / Q000235:genetics / Q000378:metabolism; D008302:Mali / Q000208:ethnology; D009154:Mutation; D010375:Pedigree; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis; D015223:Wolman Disease / Q000209:etiology* / Q000235:genetics
D017931:DNA Primers; D012333:RNA, Messenger; D008049:Lipase